Showing results (381-390 of 623) with videos related to

Sort By:
Pageof 63
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18R Debets, J C Timans, T Churakowa, et al.
The Journal of Clinical Investigation|December 1, 1993
Potential role for interleukin-10 in the immunosuppression associated with kala azarB J Holaday, M M Pompeu, S Jeronimo, et al.
Nature Communications|November 1, 2017
Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasisLiang Zhao, Chelsea L Thorsheim, Aae Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2008
Loss of PIP5KIbeta demonstrates that PIP5KI isoform-specific PIP2 synthesis is required for IP3 formationYanfeng Wang, Xinsheng Chen, Lurong Lian, et al.
International Immunology|September 1, 1995
Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cellsR de Waal Malefyt, J S Abrams, S M Zurawski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 1999
APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motifE E Bates, N Fournier, E Garcia, et al.
Academic Pediatrics|September 2, 2022
United States Youth Arrest and Health Across the Life Course: A Nationally Representative Longitudinal StudyDestiny G Tolliver, Laura S Abrams, Christopher Biely, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2014
Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancerShakun M Malik, Richard Pazdur, Jeffrey S Abrams, et al.
Pageof 63